TPP Raises Concerns About Drug Patents, Pricing and Availability

The Trans-Pacific Partnership could affect pharmaceutical pricing around the globe if ratified and implemented by the dozen signatory countries, and is a big concern to physician advocates on the front lines of ensuring advanced medicines are available and affordable in developing countries. Learn more here. (Source: Jaclyn Schiff, Modern Healthcare, 6/4/16)

You might also be interested in:

Gottlieb’s Statement on Administration Funding Request February 19, 2018
Survey: Most Support Right to Affordable Care March 9, 2018
Bringing the Inside Out: Chart abstraction methodologies that… March 19, 2018
Anthem Revises Outpatient Imaging Policy; No MRIs, CT Scans August 29, 2017
ICER Announces Final Modified Framework for Assessing Value of… November 16, 2017
The ROI of Orphan Drugs: Ensuring Optimal Returns December 12, 2017
Incoming Novartis CEO Looks to Break from Herd December 1, 2017